Pharmaceuticals
Indian pharma is its own ecosystem — payer mix, regulatory pathways, and provider behaviour that imported playbooks miss. We bring that fluency to your commercial strategy.
The challenge · Market access bottlenecks, pricing strategies that don't reflect the actual buyer mix, channel partner inefficiency, and commercial ops that haven't matured with the product.
Three priorities we tackle first.
Market access strategy
Payer pathway mapping, government tender readiness, and provider engagement built for the Indian context.
Pricing & commercial design
Pricing analytics tied to real payer mix, channel margin design, and commercial team operating models.
Field operations
Sales force structure, territory design, and incentive frameworks that hold up over time.
Engagements we typically run.
Specific service lines we lead for pharmaceuticals.
Most engagements don't fit a neat category.
If your organisation sits across two or three of these, that's usually the sign of an interesting engagement. Tell us where you are and we'll map the shape of the work.
What you get
- A 30-minute intro call
- A 2-page engagement note
- A clear next step